O-0017 * OBSERVED BENEFIT OF AFLIBERCEPT IN MCRC PATIENTS >=65 YEARS OLD: RESULTS OF A PRESPECIFIED AGE-BASED ANALYSIS OF THE VELOUR STUDY
Ruff, P., Ferry, D., Papamichael, D., Lakomy, R., Prausova, J., van Hazel, G., Moisyenko, V., Soussan-Lazard, K., Bhargava, P., Van Cutsem, E., Macarulla, T.Volume:
24
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdt201.17
Date:
June, 2013
File:
PDF, 32 KB
english, 2013